Clinical Trial Update: Metformin Postpartum for GDM RCT for Reduced Weight Retention [Phase 4]

View source ↗

Summary

Phase 4 trial update on metformin postpartum for gestational diabetes to assess reduced weight retention; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Diabetes, Gestational | Phase 4 | Status: COMPLETED | Results posted: 2018-11-28